In fact, several studies have observed that the genetic alteration of CLU or the administration of ApoJ-mimetic peptides in AD transgenic mouse models are able to modulate the Aβ load and/or its intracerebral distribution [51–55]. The gene discussed is CLU; the disease is Alzheimer disease.